Zami Aberman, CEO & Chairman at PLURISTEM THERAPEUTICS INC (PSTI), bought 25,500 shares at $2.10 ($54K) on 2015-09-21, disclosed to the SEC on 2015-09-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.10 | 14,000 | $29K | 54.7% |
| 2 | $2.12 | 11,500 | $24K | 45.3% |
| Total | $2.11 avg | 25,500 | $54K | 100% |
| Filing → |
| PSTI | BUY | 2019-04-08 | $100K | — | Filing → |
| PSTI | BUY | 2016-02-24 | $7K | — | Filing → |
| PSTI | BUY | 2016-02-17 | $16K | — | Filing → |